SFTPF: Key Regulator of Healthy Skin Development (G207107)

Target Name: SFTA1P

NCBI ID: G207107

SFTA1P

Other Name(s): SFTPF | Surfactant associated 1, lncRNA | surfactant associated 1, lncRNA

SFTPF: Key Regulator of Healthy Skin Development

SFTA1P (SFTPF) is a protein that plays a crucial role in the development and maintenance of healthy skin. It is a key regulator of the filamentous growth phase of epithelial cells, which is responsible for creating the structure and function of the skin.

SFTPF is a member of the SFP family, which includes proteins that are involved in a variety of cellular processes, including cell signaling, DNA replication, and cell division. SFTPF is specifically involved in the regulation of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs.

SFTPF is involved in many different processes in the skin, including the development and maintenance of the epidermis, which is the outermost layer of the skin. The epidermis is responsible for creating and maintaining a barrier that protects the skin from the external environment. This barrier is made up of a variety of cells, including epithelial cells, which are responsible for creating the structure and function of the skin.

SFTPF is also involved in the regulation of the growth and differentiation of epithelial cells. During the growth phase of the epidermis, SFTPF helps to control the number of cells that are produced and the structure of these cells. This is important for the development and maintenance of the strong barrier that makes up the epidermis.

In addition to its role in cell-cell adhesion and growth and differentiation, SFTPF is also involved in the regulation of the mechanical properties of the skin. This is important for the maintenance of a flexible and strong skin structure, which is necessary for many different activities, including movement and protection from the external environment.

SFTPF is a protein that is expressed in many different tissues and cells in the body. It is primarily expressed in the skin, but is also found in other tissues and organs, including the heart, the lungs, and the brain.

While SFTPF is involved in many important processes in the body, it is also a potential drug target. Many studies have suggested that SFTPF may be a useful target for the development of new treatments for a variety of skin diseases, including eczema, psoriasis, and dermatitis.

One of the reasons why SFTPF may be a good drug target is that it is involved in the regulation of many different processes in the skin. This makes it a likely candidate for the development of drugs that can disrupt these processes and treat a variety of skin diseases.

Another reason why SFTPF may be a good drug target is that it is a protein that is widely expressed in many different tissues and cells in the body. This makes it a likely candidate for the development of drugs that can interact with it in a variety of ways.

In addition to its potential as a drug target, SFTPF is also a valuable biomarker for the diagnosis and treatment of skin diseases. Because it is involved in the regulation of many different processes in the skin, it can be used as a marker for the severity and progression of these diseases.

Overall, SFTPF is a protein that plays a crucial role in the development and maintenance of healthy skin. It is a key regulator of cell-cell adhesion and growth and differentiation, and is also involved in the regulation of the mechanical properties of the skin. As a result, it may be a valuable drug target and a useful biomarker for the diagnosis and treatment of skin diseases.

Protein Name: Surfactant Associated 1, LncRNA

The "SFTA1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SFTA1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets